Lansdowne Partners Healthcare News

This is selected healthcare news for Lansdowne Partners, which is filed under Capital Firms. There are 22 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
11/9/2022 Investors Pump $85M into Blood Testing Startup | mddionline.com
... blood testing technology, Osler Origin, with buy-in from M&G Investments, a strategic investor, and returning investors Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners. Based in Oxford, England, Osler was spun out of Oxford University in 2017. Osler currently maintains a staff of more than 100 employees ...
MDDI
11/7/2022 Osler Diagnostics Raises $85 Million in Series C Financing
... C financing. The financing round included investment from a strategic investor, M&G Investments, and existing investors, including Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners. This investment will support Osler in advancing its breakthrough Osler Origin product through regulatory activities, and towards market launch. The Osler Origin is ...
Yahoo News
11/7/2022 Osler Diagnostics Raises $85 Million in Series C F
... C financing. The financing round included investment from a strategic investor, M&G Investments, and existing investors, including Oxford Science Enterprises, Braavos Investment Advisers, and Lansdowne Partners. This investment will support Osler in advancing its breakthrough Osler Origin product through regulatory activities, and towards market launch. The Osler Origin is ...
wapakdailynews.com
9/10/2022 31,000 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by Lansdowne Partners UK LLP
Lansdowne Partners UK LLP bought a new position in shares of Moderna, Inc. ( NASDAQ:MRNA ‚Ai Get Rating ) in the 1st quarter, Holdings Channel reports. The fund bought 31,000 shares of the company's stock, valued at approximately $5,340,000. Moderna accounts for 0.4% of Lansdowne Partners UK LLP's portfolio ...
The Markets Daily
9/10/2022 Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Lansdowne Partners UK LLP
Lansdowne Partners UK LLP reduced its position in shares of Illumina, Inc. ( NASDAQ:ILMN ‚Ai Get Rating ) by 86.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 52,715 shares of the life sciences company's stock after selling ...
Mayfield Recorder
9/10/2022 Lansdowne Partners UK LLP Has $18.42 Million Holdings in Illumina, Inc. (NASDAQ:ILMN)
Lansdowne Partners UK LLP lessened its stake in shares of Illumina, Inc. ( NASDAQ:ILMN ‚Ai Get Rating ) by 86.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 52,715 shares of the life sciences company's stock ...
modernreaders.com
7/25/2022 Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA
... announced its launch with $55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay's portfolio of next-generation genomic medicine technologies aims to solve the key challenges currently limiting clinical ...
Yahoo News
7/25/2022 Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA
... announced its launch with $55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay's portfolio of next-generation genomic medicine technologies aims to solve the key challenges currently limiting clinical ...
Globe Newswire
7/25/2022 Replay launches with $55M to reprogram biology by writing and delivering big DNA
Replay, a genome writing company reprogramming biology by writing and delivering big DNA, has launched with $55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay, which is based in San ...
labiotech.eu
7/25/2022 Replay Launches with $55 Million Seed to Reprogram Biology
... announced its launch with $55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay's portfolio of next-generation genomic medicine technologies aims to solve the key challenges currently limiting clinical ...
Globe Newswire
7/17/2022 Investor in Oxford University spin-offs raises £215m
... the UK government banned in 2020 as a supplier of kits for the UK's 5G mobile networks. OSE's other shareholders include Braavos Capital, Lansdowne Partners, the University of Oxford Endowment Fund, the Wellcome Trust and Temasek. OSE will use the £250m secured by the rights issue to increase ...
shepherdgazette.com
5/26/2022 EXCLUSIVE: Moa nets $44m Series B funding to launch the next generation of herbicides
... taking a new approach to the discovery of effective and sustainable alternatives. The Series B round was co-led by a new investor, London-based Lansdowne Partners , alongside existing UK investors Oxford Sciences Innovation and Parkwalk Advisors . Other early Moa backers including Chinese agrifoodtech VC Bits x Bites , the UK ...
agfundernews.com
5/24/2022 Illumina, Inc. (NASDAQ:ILMN) Position Boosted by Lansdowne Partners UK LLP
Lansdowne Partners UK LLP increased its holdings in Illumina, Inc. ( NASDAQ:ILMN ‚Ai Get Rating ) by 6.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 394,314 shares of the life sciences company's stock after purchasing ...
rivertonroll.com
5/24/2022 Lansdowne Partners UK LLP Cuts Position in Analog Devices, Inc. (NASDAQ:ADI)
Lansdowne Partners UK LLP lowered its holdings in shares of Analog Devices, Inc. ( NASDAQ:ADI ‚Ai Get Rating ) by 0.7% during the 4th quarter, Holdings Channel reports. The fund owned 986,087 shares of the semiconductor company's stock after selling 7,345 shares during the period. Analog Devices makes up approximately ...
dispatchtribunal.com
10/16/2021 Lansdowne Partners UK LLP Makes New $108.77 Million Investment in Illumina, Inc. (NASDAQ:ILMN)
Lansdowne Partners UK LLP bought a new position in Illumina, Inc. (NASDAQ:ILMN) in the second quarter, Holdings Channel.com reports. The institutional investor bought 229,868 shares of the life sciences company's stock, valued at approximately $108,765,000. Illumina accounts for approximately 4.3% of Lansdowne Partners UK LLP's portfolio, making ...
theenterpriseleader.com
8/18/2021 Lansdowne Partners (uk) Llp Buys Illumina Inc, Eaton Corp PLC, Warner Music Group Corp, Sells ...
Lansdowne Partners (uk) Llp] ( [Current Portfolio] ) buys Illumina Inc, Eaton Corp PLC, Warner Music Group Corp, Delta Air Lines Inc, AerCap Holdings NV, sells Applied Materials Inc, General Electric Co, Taiwan Semiconductor Manufacturing Co, Consolidated Edison Inc, Lam Research Corp during the 3-months ended 2021Q2, according to the most ...
google.com
8/17/2021 Lansdowne Partners (uk) Llp Buys Illumina Inc, Eaton Corp PLC, Warner Music Group Corp, Sells ...
Lansdowne Partners (uk) Llp] ( [Current Portfolio] ) buys Illumina Inc, Eaton Corp PLC, Warner Music Group Corp, Delta Air Lines Inc, AerCap Holdings NV, sells Applied Materials Inc, General Electric Co, Taiwan Semiconductor Manufacturing Co, Consolidated Edison Inc, Lam Research Corp during the 3-months ended 2021Q2, according to the most ...
gurufocus.com
7/11/2020 Weekly Commentary: Utmost Crazy
... commodities and currencies. Financial conditions have loosened markedly, with risk markets in the throes of a historic short squeeze. July 8 - Financial Times (Laurence Fletcher): “Lansdowne Partners' decision this week to shut its flagship hedge fund has dealt a big blow to a key strategy - equity long/short - that is ...
blogspot.com
7/11/2020 Doug Noland’s Credit Bubble Bulletin: Utmost Crazy
... commodities and currencies. Financial conditions have loosened markedly, with risk markets in the throes of a historic short squeeze. July 8 - Financial Times (Laurence Fletcher): “Lansdowne Partners' decision this week to shut its flagship hedge fund has dealt a big blow to a key strategy - equity long/short - that is ...
wallstreetexaminer.com
7/11/2020 July 10, 2020: Utmost Crazy
... commodities and currencies. Financial conditions have loosened markedly, with risk markets in the throes of a historic short squeeze. July 8 - Financial Times (Laurence Fletcher): “Lansdowne Partners' decision this week to shut its flagship hedge fund has dealt a big blow to a key strategy - equity long/short - that is ...
mwealthm.com
5/11/2020 Opalesque Exclusive: The Corona Fighters Report 26: Asset managers who delivered in the downturn
... the first quarter's abrupt drawdown. The Lasker Fund is a long/short equities strategy. The all-weather approach builds on the work Michelakis did at Lansdowne Partners. The fund invests in a handful of sectors including financials, TMT, healthcare, and consumer. The fund's short positions reportedly drove performance this year ...
opalesque.com